DrugPipeline.net

Global Dialysis Partnering 2010 - 2016; New Report Launched

LogoThe Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

Global Anxiety Partnering 2010-2016; New Report Launched

LogoProvides understanding and access to the anxiety partnering deals and agreements entered into by the worlds leading healthcare companies.

Global Home Healthcare Market 2016 - 2020; New Report Launched

LogoHome healthcare refers to a wide range of medical products (include heart rate monitors, blood glucose level indicators, and nebulizers), services, and solutions that provide health monitoring, treatment, and physical support to patients or customers at home. People do not need to visit a hospital or any other healthcare facility to benefit from these offerings; they can be accessed in the comfort of homes. The home healthcare market offers complete solutions that include the product as well as software and support from consultants and physicians.

Teva Partnering Deals and Alliances 2010 to 2016; New Report Launched

LogoThe initial chapters of this report provide an orientation of deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 lists the top companies partnering with the company since 2010. Chapter 3 provides an overview of the leading partnering and M&A deals since 2010 to present date based on headline value.

Global Telecardiology Market 2016 - 2020; New Report Launched

LogoTelecardiology is the provision of diagnosis and health monitoring of cardiac patients by physicians and healthcare professional from a distant location with the help of ICT. It is the branch of telemedicine services, which focuses on treatment of cardiovascular diseases (CVDs). Telecardiology services enable healthcare professional to access cardiac data of patient such as cardiac test results in the form of text, images and videos.

Global Migraine Partnering 2010 to 2016; New Report Launched

LogoProvides understanding and access to the migraine partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics; New Report Launched

LogoViruses are infectious particles comprising a nucleic acid core & consisting of either DNA or RNA – and a protein coat known as a capsid. Infections attributable to viral pathogens are transmitted, directly or indirectly, from one person to another or from animal to human. Viruses replicate by exploiting the resources of their host cells, usually to the detriment of the host. As viral pathogens are exceptionally diverse, the morbidity associated with viral infections varies significantly depending on the virus in question. This report covers all viral infections, although particular focus is given to four key indications within this disease cluster: Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) and influenza. The global viral infections market was valued at $74.0 billion in 2014, and is projected to grow at a considerable Compound Annual Growth Rate (CAGR) of 6.8%, reaching $117.6 billion in 2021. Key drivers of this growth will be the expanding treatment population and uptake of recently approved highly priced antiviral agents, as well as promising late-stage candidates that are expected to be priced highly.

Global Non-Hematological Cancers Market to 2021 - Strong Growth Driven by Increased Uptake of Low Toxicity Targeted Treatments and Versatile Biologics

LogoIn 2012, there were 32.6 million people living with any type of cancer within five years of diagnosis, non-hematological cancers are thought to account for 94% of global cancer prevalence. The key cancer indications of this report, namely breast, colorectal, lung and prostate cancer, constitute approximately 51% of global cancer prevalence.

Global Liver Cirrhosis Market 2016 - 2020; New Report Launched

LogoCirrhosis of the liver (or liver fibrosis) is a serious condition in which the liver stops functioning properly due to damage and irreversible scarring of the liver tissue. The scarring of the tissue is often caused by long-term exposure to viral infections and toxins such as alcohol. Chronic viral hepatitis and non-alcoholic steatohepatitis can also cause liver cirrhosis. Alcohol-related medications, antiviral medications, and metal chelating agents are used in the treatment of the causes of liver cirrhosis while antibiotics, vitamins, corticosteroids, diuretics, beta-blockers, and laxatives are used for the treatment of the complications of the disease.

Global Hypercholesterolemia Partnering 2010 to 2016; New Report Launched

LogoThe Hypercholesterolemia Partnering 2010-2015 report provides understanding and access to the hypercholesterolemia partnering deals and agreements entered into by the worlds leading healthcare companies.